BIO-Europe Spring® 2018: Commercializing cell and gene therapies

With the advancements in cell and gene therapies, these experts dive into some of the pending questions for commercializing: What strategies do companies need to fulfill the unique requirements for commercializing these treatments? What types of partnerships are needed to create the necessary infrastructure to bring these technologies to market? How are hospitals, CMOs, and other stakeholders taking an active role in providing new solutions for the clinical development and manufacturing of these products? What strategies need to be developed in advance to ensure that these treatments are accessible?